Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Inflammatory Breast Neoplasms × Fluorouracil × Clear all

Phase

Phase 3 4 Phase 2 3 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 70 Rectal Neoplasms 38 Pancreatic Neoplasms 31 Colonic Neoplasms 31 Neoplasms 29 Stomach Neoplasms 22 Neoplasm Metastasis 22 Carcinoma, Non-Small-Cell Lung 18 Esophageal Neoplasms 16 Unspecified Adult Solid Tumor, Protocol Specific 15 Head and Neck Neoplasms 13 Adenocarcinoma 11 Squamous Cell Carcinoma of Head and Neck 10 Breast Neoplasms 10 Ovarian Neoplasms 8 Lung Neoplasms 8 Lymphoma, Non-Hodgkin 6 Esophageal Squamous Cell Carcinoma 6 Carcinoma, Renal Cell 6 Solid Tumor 5 Lymphoma 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Gallbladder Neoplasms 5 Adenocarcinoma Of Esophagus 5 Triple Negative Breast Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Peritoneal Neoplasms 4 Melanoma 4 Liver Neoplasms 4 Hodgkin Disease 4

Interventions

Trastuzumab 3 Cyclophosphamide 3 pembrolizumab 2 Radiotherapy 2 Filgrastim 2 Epirubicin 2 Carboplatin 2 tipifarnib 1 pegfilgrastim 1 olaparib 1 aldesleukin 1 Thiotepa 1 Tamoxifen 1 Semaxinib 1 Peripheral Blood Stem Cell Transplantation 1 Interleukin-12 Subunit p35 1 Interleukin-12 1 Immunohistochemistry 1 Fluorouracil 1 Fluorescent Antibody Technique 1 Flow Cytometry 1 Doxorubicin 1 Docetaxel 1 Diathermy 1 Capecitabine 1 Biopsy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01880385 2013-06-19

Beva

Association Tunisienne de lutte Contre le Cancer

Phase 1 Unknown

Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡